BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8382111)

  • 1. Aberrations of p53 gene in human hepatocellular carcinoma from China.
    Li D; Cao Y; He L; Wang NJ; Gu JR
    Carcinogenesis; 1993 Feb; 14(2):169-73. PubMed ID: 8382111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B, aflatoxin B(1), and p53 codon 249 mutation in hepatocellular carcinomas from Guangxi, People's Republic of China, and a meta-analysis of existing studies.
    Stern MC; Umbach DM; Yu MC; London SJ; Zhang ZQ; Taylor JA
    Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):617-25. PubMed ID: 11401911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines.
    Hsu IC; Tokiwa T; Bennett W; Metcalf RA; Welsh JA; Sun T; Harris CC
    Carcinogenesis; 1993 May; 14(5):987-92. PubMed ID: 8389256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aflatoxin and p53 abnormality in duck hepatocellular carcinoma.
    Imazeki F; Yokosuka O; Ohto M; Omata M
    J Gastroenterol Hepatol; 1995; 10(6):646-9. PubMed ID: 8580407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China.
    Fujimoto Y; Hampton LL; Wirth PJ; Wang NJ; Xie JP; Thorgeirsson SS
    Cancer Res; 1994 Jan; 54(1):281-5. PubMed ID: 7903205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P53 tumor suppressor gene mutations in hepatocellular carcinoma patients in India.
    Katiyar S; Dash BC; Thakur V; Guptan RC; Sarin SK; Das BC
    Cancer; 2000 Apr; 88(7):1565-73. PubMed ID: 10738214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The point mutation of p53 gene exon7 in hepatocellular carcinoma from Anhui Province, a non HCC prevalent area in China.
    Liu H; Wang Y; Zhou Q; Gui SY; Li X
    World J Gastroenterol; 2002 Jun; 8(3):480-2. PubMed ID: 12046074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the p53 tumor suppressor gene in tree shrew hepatocellular carcinoma associated with hepatitis B virus infection and intake of aflatoxin B1.
    Park US; Su JJ; Ban KC; Qin L; Lee EH; Lee YI
    Gene; 2000 Jun; 251(1):73-80. PubMed ID: 10863098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour suppressor p53 and Rb genes in human hepatocellular carcinoma.
    Lin Y; Shi CY; Li B; Soo BH; Mohammed-Ali S; Wee A; Oon CJ; Mack PO; Chan SH
    Ann Acad Med Singap; 1996 Jan; 25(1):22-30. PubMed ID: 8779541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan.
    Lunn RM; Zhang YJ; Wang LY; Chen CJ; Lee PH; Lee CS; Tsai WY; Santella RM
    Cancer Res; 1997 Aug; 57(16):3471-7. PubMed ID: 9270015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An aflatoxin-associated mutational hotspot at codon 249 in the p53 tumor suppressor gene occurs in hepatocellular carcinomas from Mexico.
    Soini Y; Chia SC; Bennett WP; Groopman JD; Wang JS; DeBenedetti VM; Cawley H; Welsh JA; Hansen C; Bergasa NV; Jones EA; DiBisceglie AM; Trivers GE; Sandoval CA; Calderon IE; Munoz Espinosa LE; Harris CC
    Carcinogenesis; 1996 May; 17(5):1007-12. PubMed ID: 8640905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. State of the p53 gene in hepatocellular carcinomas of ground squirrels and woodchucks with past and ongoing infection with hepadnaviruses.
    Rivkina MB; Cullen JM; Robinson WS; Marion PL
    Cancer Res; 1994 Oct; 54(20):5430-7. PubMed ID: 7923176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different frequencies of p53 codon-249 hot-spot mutations in hepatocellular carcinomas in Jiang-su province of China.
    Shimizu Y; Zhu JJ; Han F; Ishikawa T; Oda H
    Int J Cancer; 1999 Jul; 82(2):187-90. PubMed ID: 10389750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [p53 gene mutation in hepatocellular carcinoma].
    Jiang W; Lu Q; Pan G
    Zhonghua Wai Ke Za Zhi; 1998 Sep; 36(9):531-2. PubMed ID: 11825456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Geographic variation of p53 mutational profile in nonmalignant human liver.
    Aguilar F; Harris CC; Sun T; Hollstein M; Cerutti P
    Science; 1994 May; 264(5163):1317-9. PubMed ID: 8191284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations of the p53 tumor suppressor gene and ras oncogenes in aflatoxin hepatocarcinogenesis.
    Shen HM; Ong CN
    Mutat Res; 1996 Oct; 366(1):23-44. PubMed ID: 8921985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic alterations in hepatocellular carcinomas: association between loss of chromosome 4q and p53 gene mutations.
    Rashid A; Wang JS; Qian GS; Lu BX; Hamilton SR; Groopman JD
    Br J Cancer; 1999 Apr; 80(1-2):59-66. PubMed ID: 10389978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic aberrations in human hepatocellular carcinomas of differing etiologies.
    Wong N; Lai P; Pang E; Fung LF; Sheng Z; Wong V; Wang W; Hayashi Y; Perlman E; Yuna S; Lau JW; Johnson PJ
    Clin Cancer Res; 2000 Oct; 6(10):4000-9. PubMed ID: 11051249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infrequent mutation of p53 gene in hepatitis B virus positive primary hepatocellular carcinomas.
    Hosono S; Chou MJ; Lee CS; Shih C
    Oncogene; 1993 Feb; 8(2):491-6. PubMed ID: 8093978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-suppressor p53 gene in hepatitis C and B virus-associated human hepatocellular carcinoma.
    Shieh YS; Nguyen C; Vocal MV; Chu HW
    Int J Cancer; 1993 Jun; 54(4):558-62. PubMed ID: 8390407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.